本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Madrigal Pharmaceuticals, Inc.

528.10
+32.226.50%
成交量:20.88万
成交额:1.09亿
市值:119.94亿
市盈率:-40.51
高:535.00
开:491.39
低:491.39
收:495.88
52周最高:535.00
52周最低:265.00
股本:2,271.14万
流通股本:1,100.01万
量比:0.72
换手率:1.90%
股息:- -
股息率:- -
每股收益(TTM):-13.0355
每股收益(LYR):-21.9007
净资产收益率:-41.22%
总资产收益率:-15.78%
市净率:19.17
市盈率(LYR):-24.11

数据加载中...

2025/11/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/04

重要事件披露

Form 8-K - Current report
2025/09/11

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/05

重要事件披露

Form 8-K - Current report
2025/07/30

重要事件披露

Form 8-K - Current report